Chime CEO Britt sells 200,000 Class A shares
Chime Financial’s CEO converted 200,000 Class B shares and indirectly sold 200,000 Class A shares under a pre-arranged Rule 10b5-1 trading plan.
Rhea-AI Filing Summary
For Chime Financial, Inc. (CHYM), Chief Executive Officer and director Christopher R. Britt reported a conversion and sales of company stock on September 1, 2026. An indirect holding of 200,000 shares of Class B Common Stock held by the Britt Living Trust was converted into 200,000 shares of Class A Common Stock, with each Class B share convertible into one Class A share and having no expiration.
On the same date, the Britt Living Trust sold 166,546 Class A shares at a weighted average price of $31.9084 (individual trades between $31.54 and $32.535 per share) and sold 33,454 Class A shares at a weighted average price of $32.6656 (trades between $32.54 and $32.94 per share). These sales were made pursuant to a Rule 10b5-1 trading plan adopted on September 15, 2025. After these transactions, Britt holds 235,417 shares of Class A Common Stock directly, some of which are restricted stock units that each represent a contingent right to receive one share of Class A stock upon vesting, and also has indirect interests in additional Class B shares convertible into Class A shares through various trusts.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Conversion | Class B Common Stock F6, F1 | 200,000 | $0.00 | $0.00 |
| Conversion | Class A Common Stock F1 | 200,000 | $0.00 | $0.00 |
| Sale | Class A Common Stock F2, F3, F1 | 166,546 | $31.9084 | $5.31M |
| Sale | Class A Common Stock F2, F4, F1 | 33,454 | $32.6656 | $1.09M |
| holding | Class B Common Stock F6, F7 | -- | -- | -- |
| holding | Class B Common Stock F6, F8 | -- | -- | -- |
| holding | Class B Common Stock F6, F9 | -- | -- | -- |
| holding | Class B Common Stock F6, F10 | -- | -- | -- |
| holding | Class A Common Stock F5 | -- | -- | -- |
Footnotes (10)
- F1. The shares are held by the Britt Living Trust, for which the Reporting Person serves as trustee.
- F2. These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2025.
- F3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.54 to $32.535 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separated price within the range set forth in this footnote.
- F4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.54 to $32.94 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separated price within the range set forth in this footnote.
- F5. Certain of these securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock, subject to the applicable vesting schedule and conditions of each RSU.
- F6. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
- F7. The shares are held by the Tiger GRAT, for which William Gheen III serves as trustee.
- F8. The shares are held by held by the Aloha Trust, for which William Gheen III serves as trustee.
- F9. The shares are held by the Tiger Trust, for which William Gheen III serves as trustee.
- F10. The shares are held by the Aloha GRAT, for which William Gheen III serves as trustee.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
restricted stock units ("RSUs") financial
weighted average price financial
contingent right financial
FAQ
What stock transactions did CHYM’s CEO Christopher R. Britt report on September 1, 2026?
Were the CHYM stock sales by Christopher R. Britt made under a Rule 10b5-1 plan?
What indirect holdings or derivative interests in CHYM does the Form 4 describe?
AI-generated analysis. How Rhea-AI works. Not financial advice.